Increase Seen in COPD Hospital Admissions Since 2010 in Canada
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Sept. 11, 2023 -- The number of hospital admissions for chronic obstructive pulmonary disease (COPD) has increased rapidly since 2010 in Canada, according to a study published online Sept. 11 in CMAJ, the journal of the Canadian Medical Association.
Joseph E. Amegadzie, Ph.D., from the University of British Columbia in Vancouver, Canada, and colleagues used a comprehensive national database of hospital admissions in Canada to identify those aged 40 years and older with a main discharge diagnosis of COPD. Sex-specific, age-standardized trends in annual rates of hospital admissions were calculated for COPD for younger (40 to 64 years) and older (≥65 years) adults.
A total of 1,134,359 hospital admissions were for COPD over 16 years. The researchers found that the total number of admissions increased by 68.8 percent between 2002 and 2017. There was a 30.0 percent increase observed in the overall crude admission rate (from 368 to 479 per 100,000 population) and a 9.6 percent increase in the sex- and age-standardized admission rate (from 437 to 479 per 100,000 population). Age-standardized rates increased by 12.2, 24.4, and 29.8 percent among younger women, younger men, and older women, respectively, and decreased by 9.0 percent among older men. There was a 23.0 percent decline seen in the all-cause sex- and age-standardized admission rate during the same period.
"Our findings call into question whether progress is being made in improving COPD care and outcomes," the authors write.
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.